Jean-Yves Blay
Directeur/Bestuurslid bij INNATE PHARMA
Vermogen: 118 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jean-Yves Blay
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
20
| Public Company | Biotechnology | 20 |
Université Claude Bernard Lyon 1
4
| College/University | Other Consumer Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Yves Blay via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Founder Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO General Counsel | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Founder Director/Board Member Director/Board Member Corporate Officer/Principal | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Université d'Aix-Marseille | College/University | Chairman Graduate Degree Doctorate Degree | |
bioMERIEUX Benelux SANV
 bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Chairman Chairman Director of Finance/CFO | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| GENEURO SA | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Mérieux NutriSciences Corp.
 Mérieux NutriSciences Corp. Miscellaneous Commercial ServicesCommercial Services Mérieux NutriSciences Corp. engages in the provision of scientific service solutions to food industries. It offers offers analytical and product development solutions to prevent health risks related to food and more generally to the use of everyday consumer products. It also offers digital solutions as part of its dedicated business The company was founded by John H. Silliker and Charles M?rieux in 1967 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| INSEAD | College/University | Graduate Degree Masters Business Admin | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| ESSEC Business School | College/University | Masters Business Admin Undergraduate Degree | |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Lyon | College/University | Doctorate Degree Undergraduate Degree | |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| Transgene, Inc. | Director/Board Member Director/Board Member | ||
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Chairman | |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Chairman | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Undergraduate Degree Undergraduate Degree | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Biomerieux Pierre Fabre SA
 Biomerieux Pierre Fabre SA Medical SpecialtiesHealth Technology Biomerieux Pierre Fabre SA specializes in infectious disease diagnostics. The firm also offers coagulation diagnostics and industrial microbiology controlling services. The company manily focuses in the field of microbiology. It was founded in December, 2000 and is headquartered in Paris, France. | Medical Specialties | Chief Executive Officer Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IPSEN | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
French-American Chamber of Commerce
 French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | President | |
European Business School Group
 European Business School Group Other Consumer ServicesConsumer Services The European Business School Group functions as a college or university. The company is based in Paris, France. | Other Consumer Services | Masters Business Admin | |
HepatoChem, Inc.
 HepatoChem, Inc. Pharmaceuticals: MajorHealth Technology HepatoChem, Inc. provides pharmaceutical and biotech services. Its services include metabolite synthesis, chemical diversity, chemistry kits, metabolite structure elucidation, metabolic stability study and analytical services. The company was founded in 2008 by Marc Bazin and John T. Groves and is headquartered in Beverly, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Cancer International Research Group | Founder | ||
| Breast Cancer International Research Group Ltd. | Founder | ||
Oddo BHF SCA (Broker)
 Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
| SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
| CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 29 |
| Verenigde Staten | 14 |
| Zwitserland | 3 |
| Verenigd Koninkrijk | 3 |
| België | 2 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Health Services | 4 |
| Finance | 4 |
Operationeel
| Director/Board Member | 190 |
| Corporate Officer/Principal | 94 |
| Chairman | 59 |
| Independent Dir/Board Member | 47 |
| Undergraduate Degree | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Jean-Luc Bélingard | 40 |
| Benoît Habert | 34 |
| Alain Mérieux | 32 |
| Philippe Archinard | 24 |
| Patrick J. Langlois | 23 |
| Maïlys Ferrère | 21 |
| Hervé Eloi Dominique Brailly | 20 |
| Olivier Martinez | 19 |
| Alessandro Riva | 14 |
| Irina Staatz-Granzer | 14 |
| Marie-Yvonne Landel-Meunier | 13 |
| Sonia Quaratino | 13 |
| Hedi Brahim | 13 |
| Karsten Munk Knudsen | 12 |
| Joyson Karakunnel | 12 |
- Beurs
- Insiders
- Jean-Yves Blay
- Bedrijfsconnecties
